New hope for Hard-to-Treat breast cancer: BNT327 combo enters phase 3 trial

NCT ID NCT07173751

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 09, 2026 · Updated 6 times

Summary

This phase 3 trial tests whether adding the experimental drug BNT327 to standard chemotherapy helps people with advanced triple-negative breast cancer (TNBC) live longer without their cancer growing. Participants have TNBC that cannot be treated with current PD(L)1 immunotherapies. About 558 volunteers will be randomly assigned to receive either BNT327 plus chemo or a placebo plus chemo. Neither they nor their doctors will know which group they are in. The study measures how long it takes for the cancer to progress and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BNT327 (also called pumitamig) combined with chemotherapy drugs (nab-paclitaxel, paclitaxel, gemcitabine, carboplatin, or eribulin)
What this could lead to
If successful, this could offer a new treatment option for people with advanced triple-negative breast cancer who cannot receive standard immunotherapy, potentially slowing cancer growth and extending survival.
What could go wrong
This is a large phase 3 trial, but the drug is still experimental. It may not prove more effective than chemotherapy alone, and side effects from the combination could be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 558 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Sep 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are considered ineligible for combination treatment with a monospecific PD(L)1 targeting immunotherapy plus chemotherapy as per their tumor PD-L1 expression status. * Have confirmed locally recurrent inoperable or metastatic TNBC, or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative breast cancer (ER and/or progesterone receptor \[PgR\]) 1% to 10%, HER2 immunohistochemistry \[IHC\] 0, 1+, or 2+ with fluorescence in situ hybridization \[FISH\] negative for HER2 gene amplification) documented prior to trial screening as part of standard of care. * Have at least one measurable lesion as the targeted lesion based on RECIST v1.1. * Have provided a tissue sample, archival or fresh, during the screening period (bone biopsies, fine needle aspiration biopsies, and samples from pleural or peritoneal fluid are not acceptable; participants with only one target lesion are not eligible to participate in the trial). * Eastern cooperative oncology group (ECOG) performance status of 0 or 1. Exclusion Criteria: * Have received any of the following therapies or drugs prior to the initiation of trial: * Have received prior systemic anticancer therapy for advanced disease. * Have received prior treatment with a PD(L)-1/vascular endothelial growth factor (VEGF) bispecific antibody. * Have received systemic corticosteroids (at a dosage greater than 10 milligrams \[mg\]/day of prednisone or an equivalent dose of other corticosteroids) within 7 days prior to the initiation of trial treatment. Exception: excluding local, intranasal, intraocular, intra-articular or inhaled corticosteroids, short-term use (\<= 7 days) of corticosteroids for prophylaxis (for example, prevention of contrast agent allergy) or treatment of non-autoimmune conditions (for example, delayed hypersensitivity reactions caused by exposure to allergens). * Have been vaccinated with live attenuated vaccine(s) within 4 weeks prior to initiation of trial treatment. * Have received broad-spectrum intravenous antibiotics therapy within 2 weeks prior to initiation of trial treatment. * Are pregnant or breastfeeding or are planning pregnancy or planning to father children during the trial or within 6 months after the last dose of pumitamig or placebo. * Have undergone major organ surgery, significant trauma, or invasive dental procedures (such as dental implants) within 28 days prior to the initiation of trial treatment or plan to undergo elective surgery during the trial. Placement of vascular infusion devices is allowed. * Have received allogeneic hematopoietic stem cell transplantation or organ transplantation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    181 sites in 16 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ASST Monza-Azienda Ospedaliera San Gerardo

    RECRUITING

    Monza, 20900, Italy

  • Ajou University Hospital

    RECRUITING

    Suwon, 16499, South Korea

  • Asan Medical Center (AMC)

    RECRUITING

    Seoul, 5505, South Korea

  • Associacao Feminina de Educacao e Combate ao Cancer(AFECC) - Hospital Santa Rita

    RECRUITING

    Vitória, 29043-260, Brazil

  • Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I

    RECRUITING

    Torrette, 60126, Italy

  • Azienda Unità Sanitaria Locale 2 (USL2) Lucca

    RECRUITING

    Lucca, 55100, Italy

  • Bon Secours Cancer Institute at Memorial Regional

    RECRUITING

    Mechanicsville, Virginia, 23116, United States

  • Bon Secours Cancer Institute at St. Mary's

    RECRUITING

    Richmond, Virginia, 23226, United States

  • Bon Secours St. Francis Medical Center

    RECRUITING

    Midlothian, Virginia, 23114, United States

  • Cancer Care Centers of Brevard, Inc

    RECRUITING

    Palm Bay, Florida, 32901, United States

  • Cancer Care Specialists

    RECRUITING

    Decatur, Illinois, 62526, United States

  • Cancer Care Specialists of Illinois

    RECRUITING

    O'Fallon, Illinois, 62269, United States

  • Cancer and Blood Specialty Clinic (CBSC)

    RECRUITING

    Los Alamitos, California, 90720-3309, United States

  • Carle Foundation Hospital d/b/a Carle Cancer Center

    RECRUITING

    Urbana, Illinois, 61801, United States

  • Carolina Oncology Specialists

    RECRUITING

    Charlotte, North Carolina, 28210, United States

  • Caucasus Medical Centre

    RECRUITING

    Tbilisi, 186, Georgia

  • Cedar Sinai - Samuel Oschin Cancer Center

    RECRUITING

    Los Angeles, California, 90048, United States

  • Centro Medico Austral

    RECRUITING

    Buenos Aires, C1019ABS, Argentina

  • Centro de Investigaciones Clinicas. Clinica Viedma S. A

    RECRUITING

    Viedma, R8500JYJ, Argentina

  • Centro de Pesquisa em Oncologia - Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS

    RECRUITING

    Porto Alegre, 90610-000, Brazil

  • Centro di Riferimento Oncologico (CRO)

    RECRUITING

    Aviano, 33081, Italy

  • Changde First People's Hospital

    RECRUITING

    Changde, 415003, China

  • Chiba Cancer Center

    RECRUITING

    Chiba, 260-8717, Japan

  • Chungbuk National University Hospital

    RECRUITING

    Cheongju-si, 28644, South Korea

  • Churchill Hospital - Oxford University Hospitals NHS Foundation Trust

    RECRUITING

    Oxford, OX3 7LE, United Kingdom

  • Clinica Adventista Belgrano (CAB)

    RECRUITING

    Caba, C1430EGF, Argentina

  • Edinburgh Cancer Centre-Western General Hospital

    RECRUITING

    Edinburgh, EH4 2LF, United Kingdom

  • Exelsus SRL

    RECRUITING

    San Miguel de Tucumán, T4000IAM, Argentina

  • Fakultni Thomayerova nemocnice

    RECRUITING

    Prague, 140 59, Czechia

  • Fakultni nemocnice Motol a Homolka

    RECRUITING

    Prague, 150 06, Czechia

  • Florida Cancer Specialists

    RECRUITING

    Fort Myers, Florida, 33916, United States

  • Florida Cancer Specialists North

    RECRUITING

    St. Petersburg, Florida, 33701, United States

  • Fondazione IRCCS Istituto Nazionale dei Tumori

    RECRUITING

    Milan, 20133, Italy

  • Fondazione Policlinico Universitario Campus Bio-Medico

    RECRUITING

    Roma, 00128, Italy

  • Fudan University - Shanghai Cancer Center (FUSCC)

    RECRUITING

    Shanghai, 200032, China

  • Fukushima Medical University Hospital

    RECRUITING

    Fukushima, 960-1295, Japan

  • Fundación Instituto Valenciano de Oncología

    RECRUITING

    Valencia, 46009, Spain

  • GenesisCare St Andrew's Precinct

    RECRUITING

    Adelaide, South Australia, 50000, Australia

  • Gifu University Hospital

    RECRUITING

    Gifu, 501-1112, Japan

  • Grand hospital de Charleroi

    RECRUITING

    Gilly, 6060, Belgium

  • Hakuaikai Medical Corporation Sagara Hospital

    RECRUITING

    Kagoshima, 892-0833, Japan

  • Healthpartners Regions Specialty Clinics

    RECRUITING

    Saint Louis Park, Minnesota, 55426, United States

  • Healthpartners Regions Specialty Clinics

    RECRUITING

    Saint Paul, Minnesota, 55101-2502, United States

  • High Technology Hospital Medcenter LTD

    RECRUITING

    Batumi, 6000, Georgia

  • Highlands Oncology Group

    RECRUITING

    Springdale, Arkansas, 72762, United States

  • Hiroshima City Hiroshima Citizens Hospital

    RECRUITING

    Hiroshima, 730-8518, Japan

  • Hospital General Universitario Morales Meseguer

    RECRUITING

    Murcia, 30008, Spain

  • Hospital Universitari Parc Tauli

    RECRUITING

    Sabadell, 8208, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    RECRUITING

    Madrid, 28040, Spain

  • Hospital Universitario Madrid Sanchinarro - Centro Integral Oncologico Clara Campal (CIOCC)

    RECRUITING

    Madrid, 28050, Spain

  • Hospital Universitario Reina Sofia

    RECRUITING

    Córdoba, 14004, Spain

  • Hospital Universitario Virgen De La Arrixaca (Huva)

    RECRUITING

    Murcia, 30120, Spain

  • Hospital Universitario de Badajoz

    RECRUITING

    Badajoz, 6006, Spain

  • Hull and East Yorkshire Hospitals NHS Trust - Castle Hill Hospital

    RECRUITING

    Cottingham, HU16 5JQ, United Kingdom

  • Hämatologische-Onkologische Praxis Augsburg

    RECRUITING

    Augsburg, 86150, Germany

  • IOB Institute of Oncology - Beata Maria Ana Hospital

    RECRUITING

    Madrid, 28007, Spain

  • IP Clinic Sp. z o.o.

    RECRUITING

    Lodz, 90-752, Poland

  • IRCCS-Istituto Europeo di Oncologia

    RECRUITING

    Milan, 20141, Italy

  • Imeldaziekenhuis

    RECRUITING

    Bonheiden, 2820, Belgium

  • Impar Servicos Hospitalares S/A - Hospital Brasilia

    RECRUITING

    Brasília, 71681-603, Brazil

  • Institut Oncologic Rosell - Hospital General De Catalunya

    RECRUITING

    Barcelona, 8195, Spain

  • Institut fuer Versorgungsforschung in der Onkologie

    RECRUITING

    Koblenz, 56068, Germany

  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)

    RECRUITING

    Milan, 20132, Italy

  • JPS Health Network - Trinity Springs Pavilion

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • Jiangsu Peoples Hospital

    RECRUITING

    Nanjing, 210029, China

  • KOC Pardubickeho kraje Multiscan-Pardubicka nemocnice

    RECRUITING

    Pardubice, 530 03, Czechia

  • Karmanos Cancer Center

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Kindai University Hospital

    RECRUITING

    Sakai, 590-0197, Japan

  • Klinikum Nürnberg Nord

    RECRUITING

    Nuremberg, 90419, Germany

  • Korea University Anam Hospital

    RECRUITING

    Seoul, 2841, South Korea

  • Kumamoto University Hospital

    RECRUITING

    Kumamoto, 860-8556, Japan

  • Kyoto University Hospital

    RECRUITING

    Kyoto, 606-8507, Japan

  • LLC Todua Clinic

    RECRUITING

    Tbilisi, 112, Georgia

  • LUX MED Onkologia Szpital Szamocka

    RECRUITING

    Warsaw, 1748, Poland

  • Lahey Hospital & Medical Center

    RECRUITING

    Burlington, Massachusetts, 01805, United States

  • Liga Paranaense de Combate ao Cancer - Hospital Erasto Gaertner

    RECRUITING

    Curitiba, 81520-060, Brazil

  • Linyi Cancer Hospital

    RECRUITING

    Linyi, 276001, China

  • Mammazentrum Hamburg - Brustklinik am Krankenhaus Jerusalem

    RECRUITING

    Hamburg, 20357, Germany

  • Maryland Oncology Hematology P.A.

    RECRUITING

    Columbia, Maryland, 21044, United States

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Monash University - Monash Medical Centre (MMC) - Clayton

    RECRUITING

    Melbourne, Victoria, 3168, Australia

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10461, United States

  • Multiprofile Clinic Consilium Medulla

    RECRUITING

    Tbilisi, 0168, Georgia

  • Nagoya City University Hospital

    RECRUITING

    Nagoya, 467-8602, Japan

  • Narodowy Insytut Onkologii im. Marii Sklodowskiej-Curie - Państwowy Instytut Badawczy

    RECRUITING

    Warsaw, 02-781, Poland

  • National Cancer Center

    RECRUITING

    Goyang-si, 10408, South Korea

  • National Cancer Centre Singapore

    RECRUITING

    Singapore, 168583, Singapore

  • National Center For Global Health And Medicine

    RECRUITING

    Shinjuku-Ku, 162-8655, Japan

  • National Hospital Organization Shikoku Cancer Center

    RECRUITING

    Matsuyama, 791-0280, Japan

  • New Cross Hospital - The Royal Wolverhampton NHS Trust

    RECRUITING

    Wolverhampton, WV10 0QP, United Kingdom

  • New England Cancer Specialists

    RECRUITING

    Westbrook, Maine, 04092, United States

  • North Wales Cancer Treatment C - Glan Clwyd Hospital

    RECRUITING

    Rhyl, LL18 5UJ, United Kingdom

  • Northwest Medical Specialties, PLLC

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Oncology Consultants PA

    RECRUITING

    Houston, Texas, 77024, United States

  • Oncology Consultants PA

    RECRUITING

    Houston, Texas, 77030, United States

  • Oncology Hematology West, PC dba Nebraska Cancer Specialist

    RECRUITING

    Grand Island, Nebraska, 68803, United States

  • Oncology Specialists of Charlotte Pa

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • OneR The Center For Cancer And Blood Disorders (Texas Cancer Care)

    RECRUITING

    Arlington, Texas, 76104, United States

  • OneR The Center For Cancer And Blood Disorders (Texas Cancer Care)

    RECRUITING

    Burleson, Texas, 76028, United States

  • OneR The Center For Cancer And Blood Disorders (Texas Cancer Care)

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • OneR The Center For Cancer And Blood Disorders (Texas Cancer Care)

    RECRUITING

    Weatherford, Texas, 76068, United States

  • Onkologisch-Haematologische Schwerpunktpraxis

    RECRUITING

    Bremen, 28209, Germany

  • Oregon Oncology Specialists

    RECRUITING

    Salem, Oregon, 97301, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    Bay Shore, New York, 11706, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 10028, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 10469, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 11042, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 11210, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 11702, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 11772, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 11776, United States

  • Paradigm New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 11901, United States

  • Paradigm Oncology Hematology West P.C. dba Nebraska Cancer Specialists

    RECRUITING

    Omaha, Nebraska, 68310, United States

  • Parc de Salut Mar - Hospital del Mar

    RECRUITING

    Barcelona, 8003, Spain

  • Peninsula & South Eastern Hematology and Oncology Group

    RECRUITING

    Frankston, Victoria, 3199, Australia

  • Perola Centro de Pesquisa em Oncologia

    RECRUITING

    São Paulo, 01317-001, Brazil

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, Victoria, 3000, Australia

  • Praxis Fuer Interdisziplinaere Onkologie & Haematologie

    RECRUITING

    Freiburg im Breisgau, 79106, Germany

  • Profound Research LLC at Michigan Hematology and Oncology Consultants

    RECRUITING

    Royal Oak, Michigan, 48073, United States

  • Providence Portland Medical Center

    RECRUITING

    Portland, Oregon, 97213, United States

  • Renovatio Clinical - The Woodlands Research Center

    RECRUITING

    The Woodlands, Texas, 77380, United States

  • Rochester General Hospital Lipson Cancer Institute

    RECRUITING

    Rochester, New York, 14621, United States

  • Royal Stoke University Hospital - University Hospitals of North Midlands NHS Trust

    RECRUITING

    Stoke-on-Trent, ST4 6QG, United Kingdom

  • Royal Sussex County Hospital - University Hospitals Sussex NHS Foundation Trust

    RECRUITING

    Brighton, BN2 5BE, United Kingdom

  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)

    RECRUITING

    Livingston, New Jersey, 07039, United States

  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)

    RECRUITING

    Long Branch, New Jersey, 07740, United States

  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)

    RECRUITING

    New Brunswick, New Jersey, 08901, United States

  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)

    RECRUITING

    Newark, New Jersey, 07112, United States

  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)

    RECRUITING

    Somerville, New Jersey, 08876, United States

  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)

    RECRUITING

    Toms River, New Jersey, 08755, United States

  • SRH Wald-Kliniken Gera GmbH

    RECRUITING

    Gera, 07548, Germany

  • Sacred Heart Medical Oncology Group

    RECRUITING

    Pensacola, Florida, 32504, United States

  • Saint Agnes Hospital, Clinical Research Center

    RECRUITING

    Baltimore, Maryland, 21229, United States

  • Saint John's Health Center - John Wayne Cancer Institute (JWCI)

    RECRUITING

    Santa Monica, California, 90404-2312, United States

  • Saint Luke's Hospital of Kansas City

    RECRUITING

    Kansas City, Missouri, 64111, United States

  • Saitama Medical University International Medical Center

    RECRUITING

    Hidaka, 350-1298, Japan

  • Samsung Medical Center

    RECRUITING

    Seoul, 6351, South Korea

  • Sarah Cannon Research Institute

    RECRUITING

    London, W1G 6AD, United Kingdom

  • Seoul National University Bundang Hospital (SNUBH)

    RECRUITING

    Seongnam-si, 13620, South Korea

  • Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, 3722, South Korea

  • Shandong Cancer Hospital And Institute

    RECRUITING

    Jinan, 250117, China

  • Soon Chun Hyang University Cheonan Hospital

    RECRUITING

    Cheonan, 31151, South Korea

  • Southampton General Hospital - University Hospital Southampton NHS Foundation Trust

    RECRUITING

    Southampton, SO16 6YD, United Kingdom

  • St Bartholomew's Hospital - Barts Health NHS Trust

    RECRUITING

    London, EC1A 7BE, United Kingdom

  • St Charles Bend Cancer Center

    RECRUITING

    Bend, Oregon, 97701, United States

  • St James's University Hospital - Leeds Teaching Hospitals NHS Trust

    RECRUITING

    Leeds, LS9 7TF, United Kingdom

  • St Vincent's Hospital - The Kinghorn Cancer Centre

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

  • St. Charles Cancer Center - Redmond

    RECRUITING

    Redmond, Oregon, 97756, United States

  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center

    RECRUITING

    Palo Alto, California, 94304-2201, United States

  • Stony Brook University Medical Center

    RECRUITING

    Stony Brook, New York, 11794, United States

  • Summit Medical Group PA

    RECRUITING

    Florham Park, New Jersey, 07932, United States

  • Tan Tock Seng Hospital

    RECRUITING

    Singapore, 308433, Singapore

  • Tennessee Oncology

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • The Cancer Institute Hospital of JFCR

    RECRUITING

    Kōtoku, 135-8550, Japan

  • The Central Hospital of Yongzhou - North Campus

    RECRUITING

    Yongzhou, 425000, China

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, 450052, China

  • The Royal Free Hospital - Royal Free London NHS Foundation Trust

    RECRUITING

    London, NW3 2QG, United Kingdom

  • The West Clinic, P.C. dba West Cancer Center

    RECRUITING

    Germantown, Tennessee, 38002, United States

  • Tohoku University Hospital

    RECRUITING

    Sendai, 980-8574, Japan

  • Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital

    RECRUITING

    Bunkyō City, 113-8677, Japan

  • Torbay Hosptial, South Devon Healthcare NHS Foundation Trust

    RECRUITING

    Torquay, TQ2 7AA, United Kingdom

  • UT Southwestern Medical Center at Redbird

    RECRUITING

    Dallas, Texas, 75237, United States

  • UT Southwestern Medical Center at Richardson/Plano

    RECRUITING

    Richardson, Texas, 75080, United States

  • UT Southwestern Moncrief Cancer Institute

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • Unidade de Pesquisa Clinica em Oncologia Ltda (UPCO) (Clinica Lacks)

    RECRUITING

    Pelotas, 96020-080, Brazil

  • Universidad de Navarra - Clinica Universidad de Navarra (CUN)

    RECRUITING

    Madrid, 28027, Spain

  • Universidad de Navarra - Clínica Universidad de Navarra (CUN)

    RECRUITING

    Pamplona, 31008, Spain

  • Universitair Ziekenhuis Brussel (AZ-VUB - Academisch Ziekenhuis der Vrije Universiteit Brussel)

    RECRUITING

    Brussels, 1090, Belgium

  • Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc

    RECRUITING

    Woluwe-Saint-Lambert, 1200, Belgium

  • University College London Hospitals NHS Foundation Trust

    RECRUITING

    London, NW2 1PG, United Kingdom

  • University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Haematology & Oncology Centre

    RECRUITING

    Bristol, BS2 8ED, United Kingdom

  • University Hospitals Leuven

    RECRUITING

    Leuven, 3000, Belgium

  • University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • University Of California - San Diego Moores Cancer Center

    RECRUITING

    La Jolla, California, 92037, United States

  • University Of California Davis Health System

    RECRUITING

    Sacramento, California, 95817-2229, United States

  • University Of Texas Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

  • Universitätsmedizin Mannheim GmbH

    RECRUITING

    Mannheim, 68167, Germany

  • Uniwersyteckie Centrum Kliniczne

    RECRUITING

    Gdansk, 80-214, Poland

  • Westmead Hospital

    RECRUITING

    Westmead, 2145, Australia

  • Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

    RECRUITING

    Warsaw, 04-141, Poland

  • Zhongnan Hospital of Wuhan University

    RECRUITING

    Wuhan, 430071, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.